Hi, Nice, As you appear determined to repeatedly post

New Post Public Reply Private Reply Replies (1) Message Board
Buildit niceicecream #24977
452
Hi, Nice,

As you appear determined to repeatedly post about the pay package until someone acknowledges you, I'll take the bait.

Your question:

"how many of you would pay yourself $1 million in cash and 46 million (typo... we all assume you mean the $6MM) in stock, if you lost $14 million? I'm guessing not many!"

has to be looked at with perspective. I will briefly place myself in two scenarios I see...

1) The scenario looking at only what we shareholders can currently see concretely (the scenario you appear to be projecting forward). The company is not producing revenues. The share price is in the crapper. The company is running out of options for financing and virtually out of cash.

If this is the complete picture, no, I would not issue $6MM in stock as payment, creating 30% or more in dilution, despite how hard the Team and I had worked for years to get to this point.

Issuing that amount of stock in this situation would drive the stock down further, eliminate any possible financing options still available, and possibly create a downward spiral from which the company could not recover. This in turn might drive the dreams of all the scientists I have worked with (and all the good science) into oblivion and put everyone out of a job.


Scenario 2) I know I have gathered a group of respected scientists with great vision and some very impressive products and ideas. I have created a BOD and an SAB filled with some of the top scientists in the country. I have weathered a 12-month SEC rectal exam of my company that threw my plans completely into flux. I have subsequently redirected the entire operation to confront a worldwide disaster which my company just may be equipped to address, even as my most promising, market-ready product (Excellagen) is prevented from coming to market due to these circumstances.

In doing so, I have shrugged off short-sighted purse string holders in my country and others, working hard to build connections in countries across the globe. My company has signed deals to allow my patented technology to move forward despite the fact that we barely have 2 nickels to rub together.

I have full visibility to various avenues for success coming down the pike in the near-term: NGIO IPO, CV testing results, Excellagen sales opening up, NuGenHealth revenues starting to ramp up, etc.

And let's not forget that I and much of my Team have worked tirelessly and creatively to overcome so very many obstacles, despite being underpaid at best and not paid at all in some cases.

I will now answer your question... in this scenario HELL YES, I will put together a pay package that I feel tries to reward the value of my Team and our efforts!


As you alluded to, this move can either be seen as proof of good things to come, or it can be a sign that Joe has lost his marbles.

If it's the latter, we're all screwed any way you look at it. And, frankly, since a company's value can only go as low as zero, it wouldn't be much worse if Joe put out 500MM shares.

But if Joe's confidence in finally preparing a pay package is a sign of success that we can't yet see, then this $6MM is probably insignificant in the long-run.


As I've said a number of times, this endeavor is either going to be massively rewarding, or it's going to be a total bust. $0/sh or $s/sh. Many of the bets are placed, including mine.

Happy New Year everybody... 2021 is going to be exciting here in GNBT/NGIO land!

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 21

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Decoding FS KKR's Legal Woes and Stock Woes Tonight

Updated Category News Views 29

FS KKR's Legal Quagmire Unpacked On the surface, investing in stocks might seem like a no-brainer. But when giants like FS KKR Capital Corp. (NYSE:FSK) find themselves tangled in legal webs, it's time to delve deeper and question everything we've taken as gospel. Recently, the collective anxiety in boardrooms is reflected in a class action lawsuit against FS KKR, filed by...

Continue Reading
Yukon Metals Unveils Ambitious Exploration Strategy for Birch

Updated Category News Views 148

Yukon Metals Unveils Expansion Plans for Birch Property Yukon Metals Corp. has announced its dynamic plans for the Birch Property, pushing to enhance resource identification in the mineral-rich region. This initiative focuses on a 7,000-hectare area, positioned strategically to capitalize on copper and gold resources. With collaborative efforts from local contractors,...

Continue Reading
Nuclearn Sets New Standards with Innovative AI for Nuclear Sectors

Updated Category News Views 378

Nuclearn Revolutionizes Nuclear Industry with AI Innovations In the realm of nuclear energy, efficiency and accuracy are paramount. Nuclearn has taken a bold step forward by introducing its groundbreaking Agentic AI solutions. This innovative approach is not only a technological leap but also a paradigm shift for professionals working in nuclear environments. An...

Continue Reading
Lithium Americas Secures $2.26 Billion in DOE Loan Boosting Stock

Updated Category News Views 162

Exciting Developments for Lithium Americas Corp. Lithium Americas Corp. (NYSE: LAC) is experiencing a notable surge in its stock price as it recently secured a substantial $2.26 billion loan from the U.S. Department of Energy’s (DOE) Loan Programs Office. This funding falls under the Advanced Technology Vehicles Manufacturing Loan Program, marking a significant...

Continue Reading
Quarterly Earnings Preview: North American Insights

Updated Category News Views 209

Quarterly Earnings Preview of North American North American (NYSE: NOA) is set to unveil its quarterly earnings report soon. This announcement is eagerly awaited by investors, with analysts predicting an earnings per share (EPS) of $0.86. Investors are hopeful that the earnings will not only meet these expectations but exceed them, along with offering positive guidance...

Continue Reading